ASLAN Pharmaceuticals (ASLN) Competitors $0.60 0.00 (0.00%) As of 08/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock ASLN vs. MTNB, ORGS, GLTO, ADIL, GRI, REVB, THAR, SNGX, CNSP, and WINTShould you be buying ASLAN Pharmaceuticals stock or one of its competitors? The main competitors of ASLAN Pharmaceuticals include Matinas Biopharma (MTNB), Orgenesis (ORGS), Galecto (GLTO), Adial Pharmaceuticals (ADIL), GRI Bio (GRI), Revelation Biosciences (REVB), Tharimmune (THAR), Soligenix (SNGX), CNS Pharmaceuticals (CNSP), and Windtree Therapeutics (WINT). These companies are all part of the "pharmaceutical products" industry. ASLAN Pharmaceuticals vs. Its Competitors Matinas Biopharma Orgenesis Galecto Adial Pharmaceuticals GRI Bio Revelation Biosciences Tharimmune Soligenix CNS Pharmaceuticals Windtree Therapeutics ASLAN Pharmaceuticals (NASDAQ:ASLN) and Matinas Biopharma (NYSE:MTNB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends, media sentiment and institutional ownership. Which has more volatility and risk, ASLN or MTNB? ASLAN Pharmaceuticals has a beta of 1.4, meaning that its stock price is 40% more volatile than the S&P 500. Comparatively, Matinas Biopharma has a beta of 1.31, meaning that its stock price is 31% more volatile than the S&P 500. Does the media prefer ASLN or MTNB? In the previous week, ASLAN Pharmaceuticals' average media sentiment score of 0.00 equaled Matinas Biopharma'saverage media sentiment score. Company Overall Sentiment ASLAN Pharmaceuticals Neutral Matinas Biopharma Neutral Do institutionals & insiders hold more shares of ASLN or MTNB? 58.8% of ASLAN Pharmaceuticals shares are held by institutional investors. Comparatively, 11.8% of Matinas Biopharma shares are held by institutional investors. 4.7% of ASLAN Pharmaceuticals shares are held by company insiders. Comparatively, 4.6% of Matinas Biopharma shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is ASLN or MTNB more profitable? Matinas Biopharma's return on equity of -123.06% beat ASLAN Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets ASLAN PharmaceuticalsN/A -8,454.87% -121.60% Matinas Biopharma N/A -123.06%-94.28% Which has higher valuation & earnings, ASLN or MTNB? Matinas Biopharma has lower revenue, but higher earnings than ASLAN Pharmaceuticals. Matinas Biopharma is trading at a lower price-to-earnings ratio than ASLAN Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioASLAN Pharmaceuticals$12M0.10-$44.22M-$21.92-0.03Matinas BiopharmaN/AN/A-$22.94M-$3.86-0.22 Do analysts recommend ASLN or MTNB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ASLAN Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Matinas Biopharma 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryASLAN Pharmaceuticals and Matinas Biopharma tied by winning 5 of the 10 factors compared between the two stocks. Get ASLAN Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ASLN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASLN vs. The Competition Export to ExcelMetricASLAN PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.23M$788.05M$5.48B$9.53BDividend YieldN/A4.84%4.73%4.09%P/E Ratio-0.031.3728.8623.83Price / Sales0.1025.68371.4466.13Price / CashN/A19.5635.4557.96Price / Book-0.096.688.265.54Net Income-$44.22M-$3.67M$3.25B$259.28M7 Day PerformanceN/A-5.23%-3.73%-4.67%1 Month PerformanceN/A-0.79%4.28%4.38%1 Year PerformanceN/A15.44%25.85%17.90% ASLAN Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330MTNBMatinas BiopharmaN/A$0.95-0.6%N/AN/A$4.85MN/A-0.2030ORGSOrgenesis1.2307 of 5 stars$1.01-2.9%N/AN/A$4.85M$662K0.00150News CoverageUpcoming EarningsGap UpGLTOGalecto2.3471 of 5 stars$3.60+0.3%$10.00+177.8%-76.6%$4.74MN/A-0.2340News CoverageADILAdial Pharmaceuticals2.7996 of 5 stars$0.51+12.4%$8.00+1,477.9%-55.4%$4.71MN/A-0.3520GRIGRI Bio2.0013 of 5 stars$1.99+9.3%$22.00+1,005.5%-88.7%$4.54MN/A-0.171News CoverageShort Interest ↑Gap UpREVBRevelation Biosciences0.4089 of 5 stars$3.06+3.7%N/A-96.6%$4.53MN/A-0.0110News CoverageUpcoming EarningsShort Interest ↑Gap UpHigh Trading VolumeTHARTharimmune2.9629 of 5 stars$1.66-1.5%$17.00+921.6%-61.6%$4.50MN/A-0.212News CoverageUpcoming EarningsSNGXSoligenix2.0483 of 5 stars$1.39+2.2%$6.00+331.7%-37.6%$4.44M$120K0.0020News CoverageUpcoming EarningsShort Interest ↑CNSPCNS Pharmaceuticals2.0645 of 5 stars$0.75-6.9%$25.00+3,255.3%-95.5%$4.37MN/A0.005Gap DownHigh Trading VolumeWINTWindtree Therapeutics1.9582 of 5 stars$0.99-16.8%$350.00+35,253.5%-99.9%$4.36MN/A0.0030Short Interest ↑High Trading Volume Related Companies and Tools Related Companies MTNB Alternatives ORGS Alternatives GLTO Alternatives ADIL Alternatives GRI Alternatives REVB Alternatives THAR Alternatives SNGX Alternatives CNSP Alternatives WINT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASLN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ASLAN Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share ASLAN Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ASLN Stock Alerts